Do you want to read an article? Please log in or register.
CLINICAL PROTOCOL FOR THE USE OF BIOLOGIC THERAPY IN COPD
COPD
RECOMMENDED
Related content
Asthma
Long-Term Clinical and Biological Outcomes of Biologic Therapy in Severe Asthma: 24-Month Real-World Cohort Study from Romania
J Clin Med
Mărginean C, Safta AC, Huțanu D, Budin CE, Ianosi MB, Jimborean G, Ianosi ES
doi: 10.3390/jcm15062444
RECOMMENDED
Asthma
Green Light for Response: Clinical Stratification of Response to Biologic Therapy in Severe Asthma
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Lopez-Rodríguez R, Cañas JA, Mahíllo-Fernández I, Rial MJ
doi: 10.2147/JAA.S577215
COPD
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice
Semin Respir Crit Care Med
Sartori F, Sartori G, Di Chiara C, Fantin A, Crisafulli E
doi: 10.1055/a-2693-0577
RECOMMENDED
Asthma
Clinical Remission and Its Determinants in Adult Severe Asthma Patients Receiving Biologic Therapy: A Retrospective Analysis
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Ediger D, Aktepe Sezgin EN, Tülümen Öztürk R, Çoban B
doi: 10.3390/jcm15020442
Asthma
Adherence to Biologic Therapies is Associated with Improved Clinical Outcomes and Reduced Healthcare Resource Utilization in Patients with Severe Asthma in Japan
J Asthma Allergy
Nagase H, Karsanji U, Kunishige H, Suzuki T, Vichiendilokkul A, Yuanita L, Sasakura N, Wang J, Noibi S
doi: 10.2147/JAA.S590261
RECOMMENDED
COPDPneumonia
Comparing Major COPD Triple Therapy Trials Using a Structured Multi-Criteria Decision Analysis: A Deep Dive into Patient Populations and Outcomes
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med
Cazzola M, Maniscalco M, Patella V, Calzetta L, Matera MG, Rogliani P
doi: 10.1016/j.rmed.2025.108292
RECOMMENDED
COPD
TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: up to 12 months interim analysis
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Rohde G, Vogelmeier CF, Beeh KM, Kardos P, Paulsson T, Watz H, Westermayer B, Mohan T, Noorduyn SG, Claussen J
doi: 10.1016/j.rmed.2025.108597
COPD
Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan
J Clin Med
Akiyama S, Oda K, Mizohata H, Sasakura N, Hashimoto K, Maruoka H
doi: 10.3390/jcm14134697
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5